In-vitro study of Hep-G2 and THLE-3 liver cell lines with 1.0 MHz low-intensity pulsed ultrasound

Clicks: 3
ID: 287254
2022
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #3,403 of 3,757 articles by views in Malay Journal

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 3,757 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Parametric in-vitro study was carried out using low-intensity pulsed ultrasound (LIPUS) to selectively target human-derived liver cell lines (i.e., HepG2 – cancer cell line and THLE-3 – normal liver cell line) by varying the intensity in W/m2 via voltage level control of the built LIPUS. The study aims to analyze the effect of 1.0 MHz LIPUS on human liver malignant cells with a MOSFET switcher that can regulate and generate square pulsed voltage signal at 0.14, 0.58, 1.30 and 2.31 W/cm2 intensity levels. In-vitro culture samples of HepG2 (American Type Culture Collection, Manassas, VA, USA) and THLE-3 (Invitrogen, USA) cells were grown in a humidified incubator at 37°C with 5% CO2. Cell culture medium was replaced every two days or until 90% confluence was achieved. These cells are then harvested and tested for cell viability using trypan blue fluorescent dye. From this batch, three replicates (wells) were respectively prepared to cluster the following groups: LIPUS-treated with sub-groups for different energy density level parametric values and untreated control (no LIPUS). In-vitro samples were then treated with LIPUS for 3-minutes to determine its cytotoxic index, genotoxic level thru comet score and molecular gene expression of cfos and cjun. Results showed that the LIPUS treatment at 2.31 W/cm2 had significantly reduced (p < 0.05) the viability of HepG2 cells compared to the THLE-3 cells at 1.30 and 2.31 W/cm2 intensity level, indicating cytotoxic effect of LIPUS on HepG2 at 2.31 W/cm2 and no significant damage on THLE-3 cells at the same voltage level. For genotoxic effect, the comet assay image showed that the LIPUS-treated HepG2 cells and THLE-3 cells have significant effect (p < 0.001) based on the CometScore (a computer-assisted measurements) of the tail length (TL), DNA tail % (TD), and tail moment (TM). In the same cell batch, the reverse transcription-quantitative polymerase chain reaction technique demonstrated that induced apoptosis due to the LIPUS treatment at 2.31 W/cm2 on HepG2 cells and THLE-3 cells from the elevated proapoptotic gene expression values of cfos and cjun. In summary, in-vitro study has showed that at 2.31 W/cm2 intensity level the LIPUS had caused significant cytotoxic, genotoxic and possible apoptotic effect on the malignant (HepG2) cells. While for the normal (THLE-3) hepatic cells, LIPUS have significant genotoxic and possible apoptotic effect. Thus, LIPUS can be a feasible treatment protocol in selectively discriminating the cytotoxic effect between the HepG2 malignant cells and normal THLE-3 hepatic cells
Reference Key
persistent_1760661038_68f18e2e7967d Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Galban, Nescy Leann F.
Journal Malay Journal
Year 2022
DOI
DOI not found
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.